Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism DMPK inhibitors(DM1 protein kinase inhibitors), MNK1 inhibitors(MAP kinase-interacting serine/threonine-protein kinase MNK1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neuralgia | Preclinical | United States | - |